1. 2091 A Japanese cohort study of first-line chemotherapy for metastatic colorectal cancer: The EMERaLD study. (September 2015) Authors: Takeda, K.; Amano, T.; Ohashi, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2093 Liver resection in patients treated with first-line chemotherapy for metastatic colorectal cancer: Analysis of 2-year follow-up data from a Japanese cohort study (EMERaLD study). (September 2015) Authors: Ishibashi, K.; Ishida, H.; Okada, N.; Amano, T.; Ohashi, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2100 Impact of UGT1A1 genotype and irinotecan exposure on outcomes in Japanese patients with advanced colorectal cancer treated by irinotecan-based regimens. (September 2015) Authors: Ichikawa, W.; Uehara, K.; Minamimura, K.; Tanaka, C.; Sadahiro, S.; Shinozaki, K.; Fukumoto, K.; Takii, Y.; Otsuji, T.; Kambara, T.; Gamoh, M.; Morita, S.; Ando, Y.; Arai, M.; Sugihara, M.; Sugiyama, T.; Ohashi, Y.; Sakata, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. [OP.3C.07] BLOOD PRESSURE, HEART RATE AND DOUBLE PRODUCT IN A POOLED COHORT: THE JAPAN ARTERIOSCLEROSIS LONGITUDINAL STUDY (JALS). (September 2017) Authors: Asayama, K.; Hozawa, A.; Taguri, M.; Ohkubo, T.; Tabara, Y.; Suzuki, K.; Ando, T.; Harada, A.; Ohashi, Y.; Ueshima, H.; Toyoshima, H.; Imai, Y. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics. (6th June 2013) Authors: Shirahata, A.; Fukutake, K.; Takamatsu, J.; Shima, M.; Hanabusa, H.; Mugishima, H.; Amano, K.; Takedani, H.; Tamashima, S.; Matsushita, T.; Tawa, A.; Tanaka, I.; Higasa, S.; Kosaka, Y.; Fujii, T.; Sakai, M.; Migita, M.; Kawakami, K.; Ohashi, Y.; Saito, H. Journal: Haemophilia Issue: Volume 19:Number 6(2013:Nov.) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors. Issue 1 (1st August 2016) Authors: Shinkoda, Y.; Shirahata, A.; Fukutake, K.; Takamatsu, J.; Shima, M.; Hanabusa, H.; Mugishima, H.; Takedani, H.; Kawasugi, K.; Taki, M.; Matsushita, T.; Tawa, A.; Nogami, K.; Higasa, S.; Kosaka, Y.; Fujii, T.; Sakai, M.; Migita, M.; Uchiba, M.; Kawakami, K. Journal: Haemophilia Issue: Volume 23:Issue 1(2017) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Acoustical physical constants around room temperature for Ca3TaGa1.5Al1.5Si2O14 single crystal. Issue 24 (1st November 2015) Authors: Ohashi, Y.; Kudo, T.; Yokota, Y.; Shoji, Y.; Kurosawa, S.; Kamada, K.; Yoshikawa, A. Journal: Electronics letters Issue: Volume 51:Issue 24(2015) Page Start: 1957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Association of Metabolic Syndrome With Kidney Function and Histology in Living Kidney Donors. Issue 9 (19th July 2013) Authors: Ohashi, Y.; Thomas, G.; Nurko, S.; Stephany, B.; Fatica, R.; Chiesa, A.; Rule, A. D.; Srinivas, T.; Schold, J. D.; Navaneethan, S. D.; Poggio, E. D. Journal: American journal of transplantation Issue: Volume 13:Issue 9(2013) Page Start: 2342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. M-COPA, a new Golgi disruptor, inhibited growth of RTK-addicted human cancer cells. (December 2016) Authors: Ohashi, Y.; Okamura, M.; Fang, S.; Tsutsui, S.; Tamaki, N.; Akatsuka, A.; Yoshimatsu, K.; Shiina, I.; Yamori, T.; Dan, S. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P092 QOL score changes in breast cancer patients: 2-year vs. 3-or-more-year administration of leuprorelin. (March 2015) Authors: Ohashi, Y.; Shiba, E.; Toyama, T.; Kurebayashi, J.; Noguchi, S.; Iwase, H. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗